Granulomatosis with polyangiitis (GPA) is a rare autoimmune vasculitis characterized by chronic inflammation of small- and medium-sized blood vessels.

The disease commonly affects the upper respiratory tract, lungs, and kidneys, and can lead to severe multi-organ complications if left untreated.

At Bay Biosciences, we provide high-quality Granulomatosis Polyangiitis Samples, including serum, plasma, and PBMC biospecimens, to support autoimmune disease research, biomarker discovery, and therapeutic development in GPA vasculitis.

Understanding Granulomatosis with Polyangiitis (GPA)

Granulomatosis polyangiitis, formerly known as Wegener’s granulomatosis, is a rare autoimmune disease that belongs to a group of disorders known as vasculitides and is often categorized as GPA vasculitis because the disease primarily involves inflammation and damage to blood vessels.

The disease most commonly affects:

  • Upper respiratory tract
  • Nasal passages and sinuses
  • Lungs
  • Kidneys

However, GPA can also involve the:

  • Eyes
  • Skin
  • Joints
  • Peripheral nervous system
  • Ears
  • Cardiovascular system
Granulomatosis Polyangiitis Samples

Causes of GPA

The exact cause of granulomatosis with polyangiitis remains unknown.

However, current evidence suggests that the disease develops through a combination of factors such as:

  • Genetic susceptibility
  • Environmental exposures
  • Immune system dysregulation
  • Potential infectious triggers

Like many autoimmune diseases, GPA occurs when the immune system mistakenly attacks healthy tissues.

One prominent feature of GPA is the formation of granulomas, which are organized collections of inflammatory immune cells.

These granulomas can damage surrounding tissues and contribute to organ dysfunction.

At the same time, inflammation of blood vessels (vasculitis) restricts blood flow and damages tissues supplied by affected vessels.

Researchers studying GPA vasculitis continue to investigate the complex interactions between neutrophils, autoantibodies, inflammatory cytokines, complement pathways, and genetic factors involved in disease development.

ANCA and GPA

One of the most important biomarkers associated with GPA is the presence of anti-neutrophil cytoplasmic antibodies (ANCA).

Many patients with GPA test positive for:

  • Proteinase 3 ANCA (PR3-ANCA)
  • Cytoplasmic ANCA (c-ANCA)

These autoantibodies are believed to play a central role in disease pathogenesis by activating immune cells and promoting vascular inflammation.

Because of their clinical importance, ANCA-positive patient specimens are frequently utilized in biomarker discovery, immunology research, and therapeutic development programs.

Symptoms of Granulomatosis Polyangiitis

Early symptoms are often nonspecific and may resemble common respiratory infections, contributing to delays in diagnosis.

Common Symptoms

As the disease progresses, additional manifestations may develop.

Diagnosis of Granulomatosis Polyangiitis (GPA)

Diagnosing granulomatosis with polyangiitis (GPA) can be challenging because its symptoms often resemble those of other respiratory, inflammatory, and autoimmune conditions.

As a result, healthcare providers typically rely on a combination of clinical evaluation, laboratory testing, imaging studies, and tissue biopsy findings to establish an accurate diagnosis.

Firstly, laboratory testing plays an important role in the diagnostic process.

Physicians commonly order anti-neutrophil cytoplasmic antibody (ANCA) testing, complete blood counts (CBC), inflammatory marker assessments, kidney function tests, and urinalysis.

These tests help identify signs of systemic inflammation, organ involvement, and the presence of autoantibodies frequently associated with GPA.

Secondly, Imaging studies are also valuable for detecting disease-related abnormalities, particularly in the lungs and upper respiratory tract.

Common imaging techniques include chest X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI), which can reveal inflammation, tissue damage, and structural changes associated with the disease.

Thirdly, a tissue biopsy remains one of the most reliable methods for confirming a diagnosis of GPA.

Histopathological examination also often reveals characteristic findings such as granulomatous inflammation, vasculitis, tissue necrosis, and immune cell infiltration.

Researchers frequently utilize biopsy-derived Granulomatosis Polyangiitis Samples to investigate disease mechanisms, identify novel biomarkers, and support the development of targeted therapies for GPA vasculitis.

Treatment of GPA Vasculitis

Treatment strategies focus on controlling inflammation, preventing organ damage, and maintaining long-term remission.

Common therapies include:

Corticosteroids:

High-dose corticosteroids are frequently used during active disease to rapidly reduce inflammation.

Immunosuppressive Medications

Common immunosuppressive therapies include:

  • Rituximab
  • Cyclophosphamide
  • Methotrexate
  • Azathioprine
  • Mycophenolate mofetil

Plasma Exchange:

In severe cases such as those involving kidney failure, pulmonary hemorrhage, or life-threatening vasculitis, healthcare providers may use plasma exchange as part of treatment.

Although treatment has improved outcomes significantly, disease relapse remains common, highlighting the need for continued research and therapeutic innovation.

Applications of Granulomatosis Polyangiitis Samples

Researchers utilize Granulomatosis Polyangiitis Samples across a wide range of scientific and clinical applications.

Autoimmune Disease Research

Investigating immune system dysfunction and autoimmune mechanisms involved in GPA.

Biomarker Discovery

Identifying biomarkers associated with diagnosis, disease activity, prognosis, and treatment response.

Drug Development

Supporting development of targeted therapies for GPA and related autoimmune disorders.

Precision Medicine

Characterizing molecular profiles that may help guide individualized treatment strategies.

ANCA Research

Investigating the role of autoantibodies in disease pathogenesis and progression.

Comparative Studies

Comparing GPA specimens with healthy controls and other autoimmune diseases to identify disease-specific biological signatures.

FAQ's

What are Granulomatosis Polyangiitis Samples used for?

Researchers use Granulomatosis Polyangiitis Samples to study autoimmune vasculitis mechanisms, identify disease biomarkers, and develop targeted therapies. These samples help scientists analyze immune dysregulation, vascular inflammation, and organ-specific damage in GPA.

What biospecimens are available for GPA research?

Common biospecimens include serum, plasma, peripheral blood mononuclear cells (PBMCs), and whole blood.

What is the difference between GPA vasculitis and Wegener’s disease?

GPA vasculitis and Wegener’s disease refer to the same condition. Wegener’s granulomatosis is the older name, while granulomatosis with polyangiitis (GPA) is the modern medical terminology used in clinical practice and research.

What is granulomatosis with polyangiitis ICD 10?

Granulomatosis with polyangiitis is classified under the ICD-10 coding system as M31.3, which represents necrotizing respiratory tract granulomatosis associated with systemic vasculitis.

Why are ANCA-positive samples important in GPA research?

ANCA-positive samples help researchers understand autoimmune activity in GPA. These biomarkers support disease diagnosis, track disease progression, and help identify therapeutic targets for vasculitis treatment.

Importance of High-Quality Biospecimens

The quality of biospecimens directly impacts the accuracy and reproducibility of research findings.

Well-characterized Granulomatosis Polyangiitis Samples, like those we offer at Bay Biosciences, are collected under standardized protocols to provide researchers with reliable materials for translational and clinical studies.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we provide researchers with access to a comprehensive collection of Granulomatosis Polyangiitis Samples and related biospecimens, including:

For customized specimen collections or specific requirements for autoimmune disease research, please feel free to contact us. We are always happy to help!